Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.
Saved in:
| Title: | Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. |
|---|---|
| Authors: | Sandler KA; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., Cook RR; Department of Epidemiology, Fielding School of Public Health at UCLA, Los Angeles, California., Ciezki JP; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio., Ross AE; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Pomerantz MM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Shaikh T; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Stock RG; Department of Radiation Oncology, The Icahn School of Medicine at Mount Sinai, New York, New York., Merrick GS; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, West Virginia., Demanes DJ; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Abu-Isa EI; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Wedde TB; Department of Oncology, Oslo University Hospital-Norwegian Radium Hospital, Norway., Lilleby W; Department of Oncology, Oslo University Hospital-Norwegian Radium Hospital, Norway., Krauss DJ; William Beaumont School of Medicine, Oakland University, Royal Oak, Michigan., Shaw GK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Alam R; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Reddy CA; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio., Song DY; Department of Radiation Oncology, The Icahn School of Medicine at Mount Sinai, New York, New York., Klein EA; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio., Stephenson AJ; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio., Tosoian JJ; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Hegde JV; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., Yoo SM; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., Fiano R; Department of Radiation Oncology, The Icahn School of Medicine at Mount Sinai, New York, New York., D'Amico AV; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Nickols NG; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California; Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California., Aronson WJ; Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California; Department of Urology, University of California, Los Angeles, Los Angeles, California., Sadeghi A; Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California., Greco SC; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Deville C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., McNutt T; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Reiter RE; Department of Urology, University of California, Los Angeles, Los Angeles, California., Said JW; Department of Pathology, University of California, Los Angeles, Los Angeles, California., Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Kupelian PA; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., King CR; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California. Electronic address: aukishan@mednet.ucla.edu. |
| Source: | International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Jul 15; Vol. 101 (4), pp. 883-888. Date of Electronic Publication: 2018 Apr 05. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
